← Back to patent-cliff list
CAS 130194-43-3
3(R)-Phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine
Codes: (VII)263642-6-a
Application context (from source-drug indications)
分离性焦虑R-fluoxetineAnxietyR-fluoxetineAnxiety disorderR-fluoxetine
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| R-fluoxetine | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
Ethenylbenzene→(1S)-1-phenylethane-1,2-diol→(1S)-2-{[(4-methylbenzene)sulfonyl]oxy}-1-phenylethan-1-ol→(3R)-3-Hydroxy-3-phenylpropanenitrile→(1R)-3-Amino-1-phenylpropan-1-ol→1-Chloro-4-(trifluoromethyl)benzene→3(R)-Phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine→Carbonochloridic acid methyl ester→Methyl [(3R)-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propyl]carbamate
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.